Published on August 14, 2018

Digital Medicines | DOHC

Digital Medicines Value-Based Contract Focused on Improving Patient Outcomes Established Between Desert Oasis Healthcare and Proteus Digital Health®

(August 14, 2018 – Palm Springs, CA)
Desert Oasis Healthcare (DOHC) and Proteus Digital Health®, Inc. announced today a multi-year collaboration established with a value-based contract. Enabled by Digital Medicines, this collaboration initiates a modern, “digital pathway” to improved medication adherence, demonstrated improvements in clinical outcomes, and reductions in hospital admissions for DOHC patients.

“We couldn’t be more excited to finally have a proven, FDA approved way to know when patients take their medications. It’s known that more than 50% of patients do not take their medications as prescribed. Now DOHC, like other healthcare providers, can use data from Digital Medicines to help patients get the real value out of their prescriptions and meet their health goals.”

Brian Hodgkins Pharm.D., Executive Vice President of Desert Oasis Healthcare

Proteus has a panel of more than 20 Digital Medicines that treat cardiovascular and metabolic diseases including hypertension and diabetes being prescribed to patients in the United States. They are prepared and delivered via specialty pharmacy services.

Through a value-based contract, Desert Oasis Healthcare joins a select group of health systems in the U.S. who use Digital Medicines to focus on improving outcomes in high-risk patients. Proteus has conducted several clinical studies demonstrating the clinical and economic benefits of using Digital Medicines to improve outcomes in these patients, including a successful randomized control trial in patients with uncontrolled hypertension and type 2 diabetes (J Med Internet Res 2017;19(7):e246).

“The value-based contract with Desert Oasis Healthcare means they reduce hospital admissions for their patients through greater health outcomes based on measured high levels of adherence to key cardiovascular and metabolic Digital Medicines, as well as control of blood pressure and hemoglobin A1c,” said Joe McKenna, Proteus Vice President of Customer Partnering. “The patient stays healthier and DOHC contains its costs through fewer hospital admissions.”

Press Contact

Barry Dayton
Director of Marketing
Desert Oasis Healthcare

About Desert Oasis Healthcare

Formed in 1981 as one of the first medical groups in the desert communities of southern California, Desert Oasis Healthcare (DOHC) continues to advance with changes in the healthcare market. DOHC provides primary and immediate care, home health, palliative care, clinical research studies and other services to more than 60,000 members/patients living in the greater Coachella Valley and the Morongo Basin of Riverside and San Bernardino counties. The multidisciplinary and comprehensive care programs of DOHC are committed to educating individuals on preventive health care in their daily lives, reflected in the DOHC motto, "Your Health. Your Life. Our Passion." For more information, visit

About Proteus Digital Health®

Proteus Digital Health is enabling a new category of pharmaceuticals: Digital Medicines. These include widely used drugs, formulated so they communicate when they have been ingested; a wearable patch that detects medicines and captures physiologic response; mobile applications to support patient self-care and physician decision-making; and data analytics to serve the needs of health system managers. The company has more than 450 issued patents that protect this enabling technology, and regulatory clearances in the U.S., European Union and China.

Proteus Digital Health is privately held by investors that include Carlyle, Essex Woodlands, Kaiser Permanente®, Medtronic®, Novartis®, Otsuka, and ON Semiconductor®. Further information is available at: Connect with us on Twitter @ProteusDH.